"Part of the VA Boston Healthcare System, the West Roxbury campus serves as the principal tertiary inpatient medical center for New England Veterans, offering primary care, medical and surgical services, PMRS, pain management, geriatrics, a MICU, CCU, SICU, and PCU, and features a nationally recognized acute spinal cord injury program. Normal business hours are 8 a.m. - 4:30 p.m. Emergency Department Services are available 24/7. Together, VA Boston HCS facilities care for more than 55,000 Veterans from the greater Boston area and across New England."

During the past decade, VA Boston Healthcare System conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VA Boston Healthcare System" #1 sponsor was "VA Office of Research and Development" with 3 trials, followed by "Adrian Hernandez" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Millennium Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VA Boston Healthcare System" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Harvard University" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator, "Mayo Clinic" with 2 trials as a collaborator and "University of Vermont" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "VA Boston Healthcare System" are "Coronary Artery Disease" (3 trials), "Heart Failure" (2 trials), "Acute Renal Failure" (1 trials), "COVID-19" (1 trials) and "Cardiac Sudden Death" (1 trials). Many other conditions were trialed in "VA Boston Healthcare System" in a lesser frequency.

Most popular intervention types in "VA Boston Healthcare System" are "Drug" (7 trials), "Behavioral" (1 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BCG vaccine" (1 trials), "Bare Metal Stent" (1 trials), "Blinded clopidogrel" (1 trials) and "Drug-Eluting Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "VA Boston Healthcare System" are 11 trials for "All" genders.

Currently, there are NaN active trials in "VA Boston Healthcare System". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in VA Boston Healthcare System, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in VA Boston Healthcare System, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".